Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Q3 2025 value amounting to $4.2 million.

  • Orchestra BioMed Holdings' Non-cash Items fell 6063.26% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 6063.26%. This contributed to the annual value of $3.5 million for FY2024, which is 3000.7% up from last year.
  • Orchestra BioMed Holdings' Non-cash Items amounted to $4.2 million in Q3 2025, which was down 6063.26% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Non-cash Items peaked at $46.0 million during Q1 2025, and registered a low of $3.5 million during Q4 2024.
  • For the 3-year period, Orchestra BioMed Holdings' Non-cash Items averaged around $11.1 million, with its median value being $8.2 million (2023).
  • Examining YoY changes over the last 5 years, Orchestra BioMed Holdings' Non-cash Items showed a top increase of 41067.78% in 2025 and a maximum decrease of 6489.42% in 2025.
  • Orchestra BioMed Holdings' Non-cash Items (Quarter) stood at $8.2 million in 2023, then plummeted by 57.39% to $3.5 million in 2024, then rose by 20.77% to $4.2 million in 2025.
  • Its Non-cash Items was $4.2 million in Q3 2025, compared to $4.1 million in Q2 2025 and $46.0 million in Q1 2025.